ORCA Therapeutics Competitors and Similar CompaniesClear all

Clovis Oncology's competitors and similar companies include Deciphera Pharmaceuticals and PharmaEssentia.

	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
Founding Date	Founding Date 2009	Founding Date 2003	Founding Date 2003
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more	Locations Waltham, US HQ Lawrence, US	Locations Taipei, TW HQ Shinjuku City, JP Burlington, US
Employees	Employees 4843% increase	Employees 35037% increase	Employees 4897% increase
Valuation ($)	Valuation ($) 10.6 m	Valuation ($) 2.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $148.8m (FY, 2021)	Revenue (est.) $163.4m (FY, 2023)	Revenue (est.) NT$15.6b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $3.7m (FY, 2023)	Cost of goods NT$1.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $159.6m (FY, 2023)	Gross profit NT$14.4b (FY, 2025)
Net income	Net income ($264.5m) (FY, 2021)	Net income ($194.9m) (FY, 2023)	Net income NT$5b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 357m	Total funding raised $ 714m	Total funding raised N/A